Tiefenbacher New Market Launch: Buprenorphine in Australia

Tiefenbacher New Market Launch: Buprenorphine in Australia

Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in Australia. We at Tiefenbacher Pharmaceuticals strongly believe that our…

Read More

Tiefenbacher Group draws attention to blood donation

Tiefenbacher Group draws attention to blood donation

On today's World Blood Donor Day, Tiefenbacher Group would like to actively support the Red Cross blood donation services and draw attention to blood donation and its importance for society with the…

Read More

Tiefenbacher Pharmaceuticals successfully prepared the launch of the antihistamine Bilastine as Oral Dispersible Tablet (ODT) in Germany.

Tiefenbacher New Market Launch: Bilastine as Oral Dispersible Tablet (ODT)

Tiefenbacher Pharmaceuticals successfully prepared the launch of the antihistamine Bilastine as Oral Dispersible Tablet (ODT) medicine in Germany As the allergy season is in full swing, we at…

Read More

Featured Video Play Icon

Tiefenbacher Group celebrates The International Day of Families

Today we celebrate The International Day of Families! We would like to use the International Day of Families to talk about our Tiefenbacher Group family. Since 1963 Tiefenbacher Group…

Read More

Featured Video Play Icon

TIEFENBACHER API + INGREDIENTS offers custom synthesis of intermediates & APIs

Synthesis of Active Pharmaceutical Ingredients (API) : From route scouting to lab scale development to commercial supply  Did you know that Tiefenbacher API + Ingredients not only…

Read More

Tiefenbacher Group renovation of our headquarters

Tiefenbacher Group renovation of headquarters in Hamburg

Tiefenbacher Group is keeping you updated on the ongoing renovation of our headquarters at the Port of Hamburg in Germany. This month we reopened our 3rd floor and we are happy to present you some of…

Read More

Tiefenbacher Group invites young people to Girls’ & Boys’ Day

Tiefenbacher Group invites young people to Girls’ & Boys’ Day

Tiefenbacher Group invited some of our employees' children in Hamburg to spend a day with us at our headquarters to mark Germany's Future Day for young people. The Girls’ & Boys’ Day…

Read More

Tiefenbacher Group Earth Day 2024

Tiefenbacher Group celebrates Earth Day 2024

We are pleased to inform you that TIEFENBACHER GROUP is successfully on its way to becoming climate neutral by the end of 2025*. Every year, Earth Day provides the keynote for a wide range of…

Read More

Tiefenbacher first-to-market launch: Rivaroxaban across Europe

Tiefenbacher first-to-market launch: Rivaroxaban

Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable…

Read More

Tiefenbacher Group welcomes new COO Sandip Tarate

Tiefenbacher Group welcomes new COO Sandip Tarate

We are pleased to welcome our new COO for AET Laboratories, Sandip Tarate, to Tiefenbacher Group.Sandip has joined our site in Hyderabad, India, with 23+ years of extensive experience in the…

Read More

Featured Video Play Icon

Tiefenbacher Group raises awareness of autism

Tiefenbacher Group raises awareness of autism on today's World Autism Awareness Day.The aim of World Autism Awareness Day is to draw attention to the needs and lifelong struggles of…

Read More

Featured Video Play Icon

Tiefenbacher Group greetings from DCAT Week!

Today is the last day of one of the world´s most important pharma events – DCATWeek in New York City!Our Tiefenbacher Group team sends greetings and their impressions of DCAT Week from…

Read More

Tiefenbacher Group EcoVadis silver medal

Tiefenbacher Group awarded EcoVadis silver medal!

We are excited to share that Tiefenbacher API + Ingredients has been awarded the EcoVadis Silver Medal!EcoVadis is the world’s largest provider of business sustainability ratings. The EcoVadis…

Read More

Tiefenbacher Group celebrates International Womens Day

Tiefenbacher Group celebrates International Women’s Day

Today Tiefenbacher Group celebrates International Women's Day, that's why we would like to introduce you to two valuable female employees from our company.Get to know the women who are working at…

Read More

Tiefenbacher Group draws attention to Rare Disease Day.

Tiefenbacher Group on awareness for rare disease day

Tiefenbacher Group draws attention to Rare Disease Day.Today we are focusing on awareness and generating change for the 300 million people worldwide living with rare diseases. Treatment for many rare…

Read More

Tiefenbacher Group supports Pharmacists in Ukraine

Tiefenbacher Group supports Pharmacists in Ukraine

Tiefenbacher Group supporting people in Ukraine by donating to Pharmacists without borders.The 24 February 2024, marks the second anniversary of the brutal Russian war against a sovereign Ukraine.…

Read More

Tiefenbacher Group is happy to present some of the results of the renovation and remodelling and to bring even more changes to life.

Tiefenbacher Group renovation of headquarters

Tiefenbacher Group keeping you updated on the ongoing renovation of our headquarters at the Port of Hamburg in Germany.Tiefenbacher Group is happy to present some of the results of the remodelling…

Read More

Tiefenbacher Group Chinese new year

Tiefenbacher Group wishes a Happy Chinese New Year!

The Chinese New Year is almost here.On the 10th of February, people around the world celebrate the Chinese New Year. They honour this day with carnival events, family gatherings, parades, traditional…

Read More

Tiefenbacher Group DKMS

Tiefenbacher Group together against blood cancer

Tiefenbacher Group and DKMS together against blood cancer!We are pleased to inform you that we have initiated a DKMS registration event during the last week in our headquartes in Hamburg to look for…

Read More

Tiefenbacher Group diversity

Tiefenbacher speaks out against racism and supports diversity

Tiefenbacher Group speaks out against racism and supports diversityTiefenbacher recognises its responsibility to be a force for good with its pharmaceuticals. Additionally our wider actions aim to…

Read More

Featured Video Play Icon

Tiefenbacher Group AET Laboratories 20th anniversary celebration

AET Laboratories 20th anniversary celebration was a tremendous success!Last year, we not only celebrated Tiefenbacher Group´s  60th anniversary in Hamburg, but also the 20th…

Read More

Featured Video Play Icon

Tiefenbacher Group wishes you a happy new year!

As 2023 draws to a close, the Tiefenbacher Group would like to share some of the year's highlights with you. This year we not only had our 60th anniversary to celebrate, but also many…

Read More

Tiefenbacher New Market Launch: Rivaroxaban in Canada

Tiefenbacher New Market Launch: Rivaroxaban in Canada

Tiefenbacher Pharmaceuticals successfully launches the anticoagulant Rivaroxaban on day one in CanadaWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be…

Read More

Featured Video Play Icon

Tiefenbacher Group 60 years of pioneering healthcare! 

60 years of pioneering healthcare at Tiefenbacher GroupTiefenbacher Group says “Thank you” to our colleagues from our three main locations in Hamburg (Germany), Hyderabad…

Read More

Featured Video Play Icon

Tiefenbacher Group 60 years anniversary celebration!

60 years anniversary celebrationsWe are very happy to announce that Tiefenbacher Group celebrates its 60th anniversary this year! 60 years ago, our founder and pioneer Alfred E.…

Read More

Tiefenbacher Group sustainable impact in Hyderabad/India

Tiefenbacher Group relocation of trees in Hyderabad – contribution to our India community to make life better for people and planetAt Tiefenbacher Group, we know that our responsibility as a global…

Read More

Tiefenbacher New Market Launch: generic launch Teriflunomide

Tiefenbacher New Market Launch: generic launch Teriflunomide

New market launch: Tiefenbacher Pharmaceuticals successfully launches the generic version of Teriflunomide in more than 20 European countriesTiefenbacher Pharmaceuticals has successfully prepared a…

Read More

State-of-the-art R&D facilities for powerful drug development

State-of-the-art R&D facilities for powerful drug development and manufacturing. New technology for generic, valued added, and innovative pharmaceuticalsWe, at Tiefenbacher Group, go beyond…

Read More

Tiefenbacher Group Social Day 2023: Community Engagement

Tiefenbacher Group Social Day 2023 – contribution through our social and community engagement in HamburgTiefenbacher Group employees get involved in the local community by volunteering with local…

Read More

Featured Video Play Icon

Tiefenbacher Community engagement: School in Hyderabad /India

Tiefenbacher Social Responsibility & Community engagement: New School in Hyderrabad /India – taking action to ensure a positive impact for children and a better future Tiefenbacher…

Read More

Featured Video Play Icon

TIEFENBACHER API + INGREDIENTS offers Raw Material for Animal Health 

TIEFENBACHER API + INGREDIENTS offers Raw Material for Animal Health: Companion and Farm AnimalsDid you know that Tiefenbacher API + Ingredients offers in addition to its extensive…

Read More

Featured Video Play Icon

OYSTA: Launch of new OYSTA website

Launch of new OYSTA websiteWe are happy that we have launched a new web page for OYSTA – an innovative healthcare brand which we have developed together with our partner OnDosis. With…

Read More

SFDA approves Tiefenbacher facilities

SFDA approves Tiefenbacher facilities

Tiefenbacher: Own manufacturing and laboratory facilities successfully registered by the Saudi Food and Drug Authority (SFDA) for GCC regionThe SFDA approves Tiefenbacher facilities! We are happy to…

Read More

Tiefenbacher Group is committed to becoming climate neutral

Tiefenbacher Group is committed to becoming climate neutral

Tiefenbacher Group is committed to becoming climate neutral by the end of 2025 - sustainability contribution to make life better for people and planetWe are pleased to share that TIEFENBACHER GROUP…

Read More

Featured Video Play Icon

Tiefenbacher Group: Renovating Headquarters in Hamburg

Tiefenbacher Group: Renovating Headquarters in Hamburg /Germany – an agile, open-plan work spaceTiefenbacher Group is renovating the Headquarters in Hamburg for flexible working while…

Read More

Featured Video Play Icon

Tiefenbacher Group at DCAT week 2023

Tiefenbacher Group at DCAT 2023 – Thanks for meeting us in New York City!It has been four very successful and inspiring days for TIEFENBACHER GROUP in New York City. We were delighted…

Read More

Tiefenbacher new market launch of antihistamine Bilastine in Germany (OTC).

Tiefenbacher Generic Launch: antihistamine Bilastine

Generic Launch: Tiefenbacher Pharmaceuticals successfully launches the antihistamine Bilastine for a market entry as over-the-counter (OTC) medicine in germanyGeneric drugs: As the allergy season is…

Read More

Tiefenbacher registered by United Arab Emirates Ministry of Health

Tiefenbacher registered by United Arab Emirates Ministry of Health

Tiefenbacher Group manufacturing sites have been successfully registered by the United Arab Emirates Ministry of HealthThe Tiefenbacher Group is very excited to announce that our two manufacturing…

Read More

Tiefenbacher marks World Cancer Day

Tiefenbacher marks World Cancer Day 2023

TIEFENBACHER marks 'World Cancer Day 2023' to increase awareness prevention throughout media togetherTIEFENBACHER joined to harness the power of social media to raise awareness on cancer early…

Read More

Featured Video Play Icon

Tiefenbacher Group wishes a happy Chinese New Year 2023!

We at Tiefenbacher Group appreciate the diversity of our colleagues very much and are happy to celebrate their local traditions together. This year, on the 22nd of January, people…

Read More

Featured Video Play Icon

Tiefenbacher Group wishes a healthy New Year 2023

From all over the world, we wish you a happy and healthy New Year 2023!Tiefenbacher Group wishes a everyone a healthy New Year. We hope the year 2023 will be as successful and full of…

Read More

Tiefenbacher launch Apremilast (Psoriasis)

Tiefenbacher Pharmaceuticals New Market Launch: Apremilast (Psoriasis)

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the psoriasis medication Apremilast in CanadaWe at Tiefenbacher Pharmaceuticals strive to make our…

Read More

Tiefenbacher launch of Abiraterone/Prednisolone for prostate cancer

Tiefenbacher Pharmaceuticals New Market Launch: Abiraterone for prostate cancer

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launces generic version of the prostate cancer medicines Abiraterone and the value-added product Abiraterone/PrednisoloneWe at…

Read More

Featured Video Play Icon

Thanks for visiting us at CPhI 2022 in Frankfurt!

Tiefenbacher Group: Three Successful Days at CPhI 2023 - Thank you for visiting us in Barcelona!

Read More

Featured Video Play Icon

TIEFENBACHER GROUP opens new manufacturing site in Cyprus

TIEFENBACHER GROUP opens new manufacturing site in Cyprus for drug production of high-quality pharmaceuticals – we continuously expand in novel technologies and capabilities to improve quality and…

Read More

Tiefenbacher Pharmaceuticals launch of the generic version of Apixaban, an oral anticoagulant for the prevention of (VTE), in Canada.

Tiefenbacher Pharmaceuticals New Market Launch: Apixaban anticoagulant

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the anticoagulant medicine Apixaban in CanadaWe at Tiefenbacher Pharmaceuticals are driven by enabling people…

Read More

Meet TIEFENBACHER GROUP at CPhI 2022 in Frankfurt /Germany

Meet TIEFENBACHER GROUP at CPhI in Frankfurt from 1-3 Nov and discover our latest ideas to make pharmaceuticals more affordable, more available, and better than before!We are very excited to meet our…

Read More

Tiefenbacher Pharmaceuticals launch of the generic version of Vildagliptin and the combination product Vildagliptin/Metformin in Africa.

Tiefenbacher Pharmaceuticals New Market Launch: Vildagliptin/Metformin

NEW Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the diabetes medicine Vildagliptin and Vildagliptin /Metformin in AfricaWe at Tiefenbacher Pharmaceuticals…

Read More

Tiefenbacher: Employee benefits and climate reduction goals

Environmentally friendly and health-promoting: TIEFENBACHER GROUP offers bike leasing to employeesEmployees benefits while reducing our impact on the environment with climate reduction goals – we…

Read More

Tiefenbacher Pharmaceuticals launch of the generic version of Rivaroxaban (blood thinner) to Central America, the Caribbean and Kazakhstan.

Tiefenbacher Pharmaceuticals New Market Launch: Rivaroxaban

Global market launch: TIEFENBACHER PHARMACEUTICALS expands the launch of the anticoagulant medicine Rivaroxaban to Central America and further international marketsWe at Tiefenbacher Pharmaceuticals…

Read More

Tiefenbacher Pharmaceuticals launch of the generic version of Teriflunomide for a market entry on day one after patent expiration in Canada.

Tiefenbacher Pharmaceuticals New Market Launch: Teriflunomide

NEW MARKET LAUNCH: TIEFENBACHER PHARMACEUTICALS SUCCESSFULLY LAUNCHES FIRST GENERIC VERSION OF THE MULTIPLE SCLEROSIS MEDICINE TERIFLUNOMIDE IN CANADAWe at Tiefenbacher Pharmaceuticals strive to make…

Read More

Sustainability: TIEFENBACHER GROUP becomes member of the Pharmaceutical Supply Chain Initiative (PSCI)

TIEFENBACHER GROUP becomes member of the Pharmaceutical Supply Chain Initiative (PSCI) – contribution to make life better for people and planetWe at TIEFENBACHER GROUP are committed to promote…

Read More

TIEFENBACHER GROUP OPENS NEW SITE FOR HIGHLY POTENT DRUGS IN INDIA

TIEFENBACHER GROUP opens new site for highly potent drugs in India – we continuously expand in novel technologies and capabilities to improve quality and boost productivity of better…

Read More

WORLD HEALTH DAY @ TIEFENBACHER GROUP

World Health Day is on the 7th of April each year – this day marks the anniversary of the World Health Organization which was founded in 1948.Today we celebrate World Health Day. This Day marks the…

Read More

Featured Video Play Icon

TIEFENBACHER AT DCAT 2022 IN NEW YORK CITY! – Thanks for Meeting us

TIEFENBACHER GROUP AT DCAT 2022 – THANKS FOR MEETING US IN NEW YORK CITY! One of the world´s most important pharma events – DCAT-Week in New York City – has just come to an end. It was…

Read More

Tiefenbacher Pharmaceuticals New Market Launch: Lacosamide

Tiefenbacher Pharmaceuticals New Market Launch: Lacosamide

NEW MARKET LAUNCH: TIEFENBACHER PHARMACEUTICALS SUCCESSFULLY LAUNCHES FIRST GENERIC VERSION OF THE EPILEPSY MEDICINE LACOSAMIDE IN AUSTRALIAWe at Tiefenbacher Pharmaceuticals strongly believe that…

Read More

TIEFENBACHER GROUP stands with UKRAINE

Peace and freedom for Ukraine: We, a healthcare company in Europe, stand in solidarity with the people in UkraineTo us at Tiefenbacher Group, it is unbearable to witness what is happening in Ukraine.…

Read More

MEET TIEFENBACHER GROUP DURING DCAT WEEK IN NEW YORK CITY 2022

Meet TIEFENBACHER GROUP during DCAT week in New York City 2022 from 21-24th march!Reach out to TIEFENBACHER GROUP at DCAT in New York City from 21-24th March and discover our latest ideas to make…

Read More

Featured Video Play Icon

TIEFENBACHER GROUP WISHES A HAPPY AND HEALTHY NEW YEAR 2022 FROM ALL OVER THE WORLD!

We at TIEFENBACHER GROUP wish you a happy and healthy new year 2022 from all over the world! Please watch the short video for our new year greetings from our colleagues from our three…

Read More

TIEFENBACHER GROUP enlarges its manufacturing facilities in India and Cyprus

Driving efficiency is our key – TIEFENBACHER GROUP enlarges its manufacturing facilities in India and Cyprus for powerful drug productionDid you know that TIEFENBACHER GROUP heavily invests in its…

Read More

Featured Video Play Icon

TIEFENBACHER GROUP at CPhI 2021 in Milano – thank you for visiting us!

Tiefenbacher Group: Three Successful Days at CPHI 2021 in Milano - Thank you for visiting usWith over 1,300 exhibitors and more than 20,000 attendees the world`s leading pharma eventt…

Read More

Featured Video Play Icon

TIEFENBACHER GROUP: New school building in India

At TIEFENBACHER GROUP giving back to society is important to us: New school building in India As a value-driven healthcare company, dedicated to improve the life of patients worldwide,…

Read More

TIEFENBACHER GROUP at CPhI in Milan 2021

Reach out to the TIEFENBACHER GROUP at CPHI in Milan 2021 and discover our latest innovations to make pharmaceuticals more affordable, more available, and better than before.“Nothing can replace…

Read More

Tiefenbacher Pharmaceuticals: Launch of first generic version of the antihistamine Bilastine

New market launch: TIEFENBACHER PHARMACEUTICALS successfully launches first generic version of the antihistamine BilastineWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality…

Read More

New agreement expands collaboration between OnDosis and TIEFENBACHER GROUP

Innovative Healthcare Pharmaceuticals with e-health technology in the ADHD field, rare diseases, and transplantation medicineSwedish Life science company OnDosis and German B2B pharmaceutical company…

Read More

TIEFENBACHER GROUP supports Post COVID-19 with Posaconazole against Black Fungus (Mucormycosis)

TIEFENBACHER GROUP supports Post COVID-19 with Posaconazole tablets against Black Fungus (Mucormycosis) in IndiaBlack Fungus (Mucormycosis) is dramatically spreading in India connected to the…

Read More

TIEFENBACHER GROUP announces global launch of TIEFENBACHER MEDICAL DEVICES

Innovation healthcare by combining established drug-based medicines with medical devices and digital healthAfter more than five years in operation, TIEFENBACHER GROUP transfer its medical device…

Read More

TIEFENBACHER API + INGREDIENTS: FIRST API BASED ON GREEN CHEMISTRY

TIEFENBACHER API + INGREDIENTS starts to offer the first API based on green chemistryWe at TIEFENBACHER API + INGREDIENTS are committed to drive greem chemistry in the pharmaceutical raw material…

Read More

TIEFENBACHER PHARMACEUTICALS: Launch of generic version of Teriflunomide, Multiple Sclerosis (MS)

TIEFENBACHER PHARMACEUTICALS announces global generic launch of Teriflunomide – making multiple sclerosis therapy more affordable and better available worldwideTiefenbacher Pharmaceuticals has…

Read More

AET Pharma US Inc., Part of Tiefenbacher, approval of Abbreviated New Drug Application (ANDA) for Posaconazole

AET Pharma US Inc. announces successful approval of Abbreviated New Drug Application (ANDA) for PosaconazoleOn 1st February 2021, AET Pharma US Inc, part of TIEFENBACHER GROUP, received FDA approval…

Read More

TIEFENBACHER PHARMACEUTICALS: Launch of Rivaroxaban

TIEFENBACHER PHARMACEUTICALS announces global launch of Rivaroxaban – an anticoagulant medication (blood thinner)Tiefenbacher Pharmaceuticals, part of Tiefenbacher Group, is pleased to announce the…

Read More

International Brand Relaunch of Tiefenbacher Group

Tiefenbacher Group: Improving people’s life by making pharmaceuticals more affordable, more available, and better than before“We are very excited to launch the new Tiefenbacher Group website.…

Read More

Tiefenbacher Group and OnDosis enter a partnership for medicines and digital health

Tiefenbacher Group and OnDosis today announced the signing of an extensive co-development agreement for multiple products in the upcoming years. This collaboration strengthens both companies’…

Read More